Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia.


BACKGROUND Patients with familial hypercholesterolemia (FH) have a high risk of premature cardiovascular disease (PCVD). Mutations in the LDL receptor (LDLR) gene and the R3500Q mutation in the apolipoprotein B (APOB) gene are known to cause FH, but lack of high-throughput methods makes routine genetic diagnosis difficult. The objective of this work was to develop a DNA array for large-scale identification of mutant LDLR alleles. METHODS We developed a low-density oligonucleotide microarray to identify 118 DNA sequence variations (117 for the LDLR gene and 1 for the APOB gene). We verified specificity and sensitivity by analyzing 1180 previously sequenced DNA samples, and conducted a blind study screening 407 Spanish patients with a clinical diagnosis of FH. RESULTS The DNA array confirmed the previous genotyping results in almost all cases. In the blind study, the microarray detected at least 1 mutation in 51% of the patients for whom clinical diagnosis was classified as certain according to Dutch FH-MEDPED criteria; it also identified mutations in 37% of those with a diagnosis of probable/possible FH, thus giving a definite diagnosis. Patients harboring null mutations had shorter PCVD-free survival times and higher relative risk of PCVD than patients with a missense mutation. CONCLUSIONS The proposed DNA array allows large-scale population screening and provides molecular information regarding mutation type and its correlation with clinical severity of FH, which can be used to develop therapeutic strategies.

6 Figures and Tables

Citations per Year

435 Citations

Semantic Scholar estimates that this publication has 435 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Tejedor2005ReliableLD, title={Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia.}, author={Diego Tejedor and Sergio F. Castillo and Pilar Mozas and Elisa Jim{\'e}nez and Monica Lopez and Mar{\'i}a Teresa Tejedor and Marta Artieda and Rodrigo Alonso and Pedro L Mata and Laureano Sim{\'o}n and Antonio Mart{\'i}nez and Miguel Pocovi}, journal={Clinical chemistry}, year={2005}, volume={51 7}, pages={1137-44} }